0001213900-23-007992.txt : 20230203
0001213900-23-007992.hdr.sgml : 20230203
20230203161355
ACCESSION NUMBER: 0001213900-23-007992
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230202
FILED AS OF DATE: 20230203
DATE AS OF CHANGE: 20230203
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: MARTELL RON
CENTRAL INDEX KEY: 0001177079
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39138
FILM NUMBER: 23585922
MAIL ADDRESS:
STREET 1: PONIARD PHARMACEUTICALS, INC.
STREET 2: 750 BATTERY STREET, SUITE 330
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94111
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Jasper Therapeutics, Inc.
CENTRAL INDEX KEY: 0001788028
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 842984849
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2200 BRIDGE PKWY SUITE #102
CITY: REDWOOD CITY
STATE: CA
ZIP: 94065
BUSINESS PHONE: 6505491400
MAIL ADDRESS:
STREET 1: 2200 BRIDGE PKWY SUITE #102
CITY: REDWOOD CITY
STATE: CA
ZIP: 94065
FORMER COMPANY:
FORMER CONFORMED NAME: Amplitude Healthcare Acquisition Corp
DATE OF NAME CHANGE: 20190912
4
1
ownership.xml
X0306
4
2023-02-02
0
0001788028
Jasper Therapeutics, Inc.
JSPR
0001177079
MARTELL RON
C/O JASPER THERAPEUTICS, INC.
2200 BRIDGE PKWY, SUITE 102
REDWOOD CITY
CA
94065
1
1
0
0
President, CEO & Director
Stock Option (right to buy)
1.78
2023-02-02
4
A
0
1093831
0.00
A
2033-02-02
Voting Common Stock
1093831
1093831
D
1/4th of the shares subject to the option shall vest on February 2, 2024, and 1/48th of the shares subject to the option shall vest following each one-month period thereafter, subject to the Reporting Person's continuous service to the Issuer on and through each applicable vesting date, inclusive.
/s/ Ronald A. Martell
2023-02-03